Literature DB >> 31904413

Role of oxygen and the HIF-pathway in polycystic kidney disease.

Bjoern Buchholz1, Kai-Uwe Eckardt2.   

Abstract

Kidney cyst growth in ADPKD is associated with regional hypoxia, presumably due to a mismatch between enlarged cysts and the peritubular capillary blood supply and compression of peritubular capillaries in cyst walls. Regional hypoxia leads to activation of hypoxia-inducible transcription factors, with the two main HIF isoforms, HIF-1 and HIF-2 expressed in cyst epithelia and pericystic interstitial cells, respectively. While HIF-2 activation is linked to EPO production, mitigating the anemia that normally accompanies chronic kidney disease, HIF-1 promotes cyst growth. HIF-dependent cyst growth is primarily due to an increase in chloride-dependent fluid secretion into the cyst lumen. However, given the broad spectrum of HIF-target genes, additional HIF-mediated pathways may also contribute to cyst progression. Furthermore, hypoxia can influence cyst growth through the generation of reactive oxygen species. Since cyst expansion aggravates regional hypoxia, a feedforward loop is established that accelerates cyst expansion and disease progression. Inhibiting the HIF pathway and/or HIF target genes that are of particular relevance for HIF-dependent cyst fluid secretion may therefore represent novel therapeutic approaches to retard the progression of APDKD.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autosomal dominant polycystic kidney disease, ADPKD; Hypoxia; Hypoxia-inducible factor, HIF; Polycystic kidney disease, PKD

Mesh:

Substances:

Year:  2020        PMID: 31904413     DOI: 10.1016/j.cellsig.2020.109524

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  7 in total

1.  Examining the Role of Novel CKD Therapies for the ADPKD Patient.

Authors:  Dipal M Patel; Neera K Dahl
Journal:  Kidney360       Date:  2021-03-24

2.  Authors' Reply.

Authors:  Tadao Akizawa; Manabu Iwasaki; Yusuke Yamaguchi; Yoshikatsu Majikawa; Michael Reusch
Journal:  J Am Soc Nephrol       Date:  2021-03-01       Impact factor: 10.121

3.  Roxadustat for Renal Anemia in ESRD from PKD Patients: Is It Safe Enough?

Authors:  Fei Liu; Jingjing Wang; Qing Ye; Haidong Fu; Jianhua Mao
Journal:  J Am Soc Nephrol       Date:  2021-03-01       Impact factor: 10.121

4.  Macrophage migration inhibitory factor is regulated by HIF-1α and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.

Authors:  Wajima Safi; Andre Kraus; Steffen Grampp; Johannes Schödel; Bjoern Buchholz
Journal:  J Mol Med (Berl)       Date:  2020-09-04       Impact factor: 4.599

5.  cAMP-Induced Nuclear Condensation of CRTC2 Promotes Transcription Elongation and Cystogenesis in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Zeyun Mi; Yandong Song; Jiuchen Wang; Zhiheng Liu; Xinyi Cao; Lin Dang; Yumei Lu; Yongzhan Sun; Hui Xiong; Lirong Zhang; Yupeng Chen
Journal:  Adv Sci (Weinh)       Date:  2022-01-17       Impact factor: 17.521

6.  A 3D In Vivo Model for Studying Human Renal Cystic Tissue and Mouse Kidney Slices.

Authors:  Eva-Marie Bichlmayer; Lina Mahl; Leo Hesse; Eric Pion; Victoria Haller; Andreas Moehwald; Christina Hackl; Jens M Werner; Hans J Schlitt; Siegfried Schwarz; Philipp Kainz; Christoph Brochhausen; Christian Groeger; Felix Steger; Oliver Kölbl; Christoph Daniel; Kerstin Amann; Andre Kraus; Björn Buchholz; Thiha Aung; Silke Haerteis
Journal:  Cells       Date:  2022-07-22       Impact factor: 7.666

7.  Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES).

Authors:  Jonathan Barratt; Branislav Andric; Avtandil Tataradze; Michael Schömig; Michael Reusch; Udaya Valluri; Christophe Mariat
Journal:  Nephrol Dial Transplant       Date:  2021-08-27       Impact factor: 5.992

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.